## [Investor Contacts](/contacts/investor-contacts "Investor Contacts") For questions about Investor Relations or the Share Registry, please contact our team. For all other queries: **Main Switchboard** Switzerland Phone: [+41 61 324 11 11](tel:0041613241111) **US Switchboard** Phone: [+1 862 778 21 00](tel:0018627782100) - [Share Registry](#tabshare-registry-30686) - [IR Europe](#tabir-europe-30691) - [IR North America](#tabir-north-america-30696) For information regarding the share register (entries, transfers, dividends, etc.) please contact: E-mail addressPostal address**Novartis International AG** Share Registry Novartis Campus Fabrikstrasse 18 4056 Basel SwitzerlandPhone number[+41 61 324 72 04](tel:0041613247204) You can notify the Share Registry of a **change of address** using the following form: [Change of address: Online form](/investors/shareholder-address-change "Shareholder Address Change") Note: Most Swiss custodian banks automatically notify the stock corporations of their customers’ address changes to be applied in the share register. **Email address:** --- **Isabella Zinck** Phone: [+41 61 324 71 88](tel:0041613247188) --- **Parag Mahanti** Phone: [+41 79 389 84 62](tel:0041793898462) --- **Mailing address:** **Novartis International AG** Investor Relations P.O. Box CH - 4002 Basel / Switzerland Phone: [+41 61 324 79 44](tel:0041613247944) **Email address:** --- **Sloan Simpson** Head of Investor Relations Phone: [+1 862 345 44 40](tel:0018623454440) --- **Jonathan Graham** Phone: [+1 201 602 99 21](tel:0012016029921) --- **Inish O’Doherty** Phone: [+1 862 703 49 33](tel:0018627034933) --- **Mailing address:** **Novartis Pharmaceuticals** One Health Plaza East Hanover, NJ 07936